CORRECTION article

Front. Allergy, 12 January 2024

Sec. Drug, Venom & Anaphylaxis

Volume 4 - 2023 | https://doi.org/10.3389/falgy.2023.1361973

Corrigendum: Approach for delabeling beta-lactam allergy in children

  • 1. Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain

  • 2. Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Civil, Málaga, Spain

  • 3. Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Parque Tecnológico de Andalucía, Málaga, Spain

  • 4. Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain

In the published article, there was an error in the Funding statement. The following was incorrectly written: ‘The present study has been supported by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): PI21/00329, and Redes de Investigación Cooperativa Orientadas al Resultado en Salud: Enferemedades Inflamatorias (RD21/0002/0008).’

This has been replaced by ‘The present study has been funded by Instituto de Salud Carlos III through the project “PI21/00329” and co-funded by the European Union.’

The full, correct Funding statement appears below.

Statements

Funding

GB holds a contract from “Juan Rodes” program (JR18/00054) from the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness [grants co-funded by European Social Fund (ESF)]. AA holds a Senior Postdoctoral Contract (RH-0099–2020) from Andalusian Regional Ministry of Health [cofunded by European Social Fund (ESF): “Andalucía se mueve con Europa”]. The present study has been funded by Instituto de Salud Carlos III through the project “PI21/00329” and co-funded by the European Union.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

anaphylaxis, beta-lactam, children, drug provocation test, maculopapular exanthema, skin test, urticaria

Citation

Sáenz de Santa María R, Bogas G, Labella M, Ariza A, Salas M, Doña I and Torres MJ (2024) Corrigendum: Approach for delabeling beta-lactam allergy in children. Front. Allergy 4:1361973. doi: 10.3389/falgy.2023.1361973

Received

27 December 2023

Accepted

28 December 2023

Published

12 January 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

4 - 2023

Updates

Copyright

*Correspondence: M. J. Torres

† These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics